Moderna, one of the companies working on a treatment for Covid-19, said Wednesday that it’s on track to finish enrollment for a phase 3 study of its vaccine by the end of September.
Moderna, one of the companies working on a treatment for Covid-19, said Wednesday that it’s on track to finish enrollment for a phase 3 study of its vaccine by the end of September.
